2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
13144
Triple Negative Breast Neoplasms
1151
Neoplasms
751
Ovarian Neoplasms
680
Neoplasm Metastasis
591
Lung Neoplasms
583
Colorectal Neoplasms
581
Prostatic Neoplasms
560
Carcinoma, Non-Small-Cell Lung
536
Pancreatic Neoplasms
380
Melanoma
366
Stomach Neoplasms
350
Colonic Neoplasms
330
Motor Activity
285
Breast Neoplasms, Male
285
Carcinoma, Intraductal, Noninfiltrating
277
Uterine Cervical Neoplasms
267
Head and Neck Neoplasms
266
Endometrial Neoplasms
256
Carcinoma, Renal Cell
216
Sarcoma
204
Urinary Bladder Neoplasms
193
Squamous Cell Carcinoma of Head and Neck
192
Lymphedema
190
Esophageal Neoplasms
189
Breast Carcinoma In Situ
189
Brain Neoplasms
183
Fatigue
166
Carcinoma, Ovarian Epithelial
151
Small Cell Lung Carcinoma
148
Interventions
abemaciclib
1
Trastuzumab
1
Tablets
1
Genetic Testing
1
Fulvestrant
1
Everolimus
1
Blood Specimen Collection
1
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hormone Receptor Positive Breast Cancer
×
Breast
×
Clear all
NCT07646171
2026-06-12
MBC
Tel-Aviv Sourasky Medical Center
Recruiting
19 enrolled
NCT02675231
2024-11-26
monarcHER
Eli Lilly and Company
Phase 2
Completed
237 enrolled
25 charts